Carbios SAS is a French biotechnology company specializing in the development and industrialization of enzymatic bioprocesses aimed at reinventing the lifecycle of plastics and textiles, with core products and services including enzymatic PET biorecycling, biodegradation of polymers, and production of bioplastics from biological ingredients. The company operates primarily in the fields of biorecycling and biodegradation of plastic wastes, leveraging proprietary enzymes to enable the depolymerization and recycling of polyethylene terephthalate (PET) plastic waste into 100% recycled and recyclable PET. Carbios also develops biobased plastics through enzymatic processes and serves global markets, focusing on industries such as packaging, textiles, and consumer goods. Founded in 2011 and headquartered in Clermont-Ferrand, France, Carbios runs subsidiaries including Carbiolice, a joint venture focused on biodegradation technologies.
Recent major company developments include a strategic partnership and joint venture formation with China's Wankai New Materials to deploy Carbios's PET biorecycling technology at scale in Asia, supported by a €5 million capital increase subscription by Wankai. Carbios has also signed multiple multi-year commercial agreements with major players in the beverage industry to supply recycled PET, marking its entry into new strategic sectors and advancing the pre-commercialization of its industrial enzymatic recycling plant in Longlaville, France, slated for production scaling in 2026. Additionally, governance changes with the appointment of Vincent Kamel as CEO in 2025, a focus on operational expense reductions, and continued advances in licensing the enzymatic recycling technology globally underpin Carbios's growth and industrial deployment strategy. The company secures substantial public and regional funding to support its industrial projects and continues signing letters of intent with international partners for technology licensing and commercialization.